menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Prostate cancer testing now urged for men in their 50s and 60s – a lead author of the new screening guidelines explains why

21 0
15.11.2026

The American Cancer Society announced on Nov. 12, 2026, that it has released major changes to its prostate cancer screening guidelines to improve detection and treatment of the disease.

The Conversation asked Dr. Andrew Wolf, a physician at the University of Virginia who was one of the lead authors of the new guidelines, to walk readers through the changes and why they were made.

What are the new screening recommendations?

The biggest change is that we are making a proactive recommendation to screen for prostate cancer. Previously, we recommended that people talk with their healthcare provider to decide whether or not screening is right for them.

Our new recommendations vary by age and by a person’s risk of developing prostate cancer.

For people at average risk of developing prostate cancer, we recommend they be screened with the prostate-specific antigen, or PSA, blood test every two years from age 50 through 69. PSA is a protein that prostate cells make. Cancer and other conditions can cause PSA levels to rise.

People at higher risk, including Black men and men with a strong family history of prostate cancer, should be screened annually from age 45 to 69. A strong family history means having a family member who was diagnosed with prostate cancer before age 65, or multiple family members diagnosed at any age. People with a single family member diagnosed at age 65 or older should be screened every two years from age 45 years to age 69 years.

For people ages 70 to 74, we recommend they talk with their healthcare provider about whether or not to continue screening. Because there is uncertainty about the benefit of screening for people in this age group, decision-making around screening depends on their personal preferences, overall health status and life expectancy.

For those over age 74, we recommend against prostate cancer screening. The potential harms of screening, such as more invasive follow-up tests and........

© The Conversation